Manufacturing Retail Supplies 
McKensey
NOVEMBER 20, 2024
Complexity, COVID-19, and competition have upended supply chain organizations. They can reignite revenue growth and deepen resilience by deploying AI-powered digital twins.
Work Life
JUNE 10, 2024
But a growing number of companies view transparency in their supply chains and manufacturing processes as a competitive advantage, and they’re not waiting for regulators to mandate disclosures. Last week, GS1 US, a member of the GS1 standards-setting organization, convened its annual supply chain conference.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Success
DECEMBER 8, 2022
Although the brand overcame previous challenges during its dozen years in business, an abrupt and unexpected supply chain disruption due to the pandemic ultimately led Deer to cease operations in July. . K-DEER was one of the first brands to make and market printed activewear in 2010 before it became an established retail department. “I
Success
FEBRUARY 2, 2023
Burned out from a career in retail, Lisa Harper sought refuge in sleepy coastal towns on the Baja California peninsula in Mexico. fit model and later worked for the denim designer and manufacturer by flying around the world to source products. That was in the mid-1990s. Before that, she was a Levi Strauss & Co.
Success
AUGUST 14, 2024
Since its inception, the B Corp movement has grown exponentially, with more than 8,900 certified businesses in more than 101 countries, spanning 162 industries from retail and manufacturing to finance and technology. Community tackles supply chain—from raw materials to partner companies along the production process.
Workplace Insight
JANUARY 22, 2024
With many occupiers often more focused on emissions from other aspects of their businesses, such as manufacturing or supply chains, the contribution that buildings make to the aggregate 37 percent global emissions from real estate can be underestimated.
Workplace Insight
DECEMBER 14, 2023
This lack of supply is acting as a brake on the UK Government’s dream of making the country a “science superpower”. To illustrate the pull of Ireland for these sectors, AstraZeneca announced in 2021 it had chosen the Republic of Ireland for a $360 million manufacturing facility rather than Britain because of a “discouraging” tax system. “We
Expert insights. Personalized for you.
139 
Let's personalize your content